Unmatched oncology expertise to take your therapeutic idea further
Breakthroughs in cancer science too often fail to reach the people who need them most. Not because the science isn’t good enough, but because turning a promising discovery into a therapeutic takes more than great science — it requires the right expertise, guidance and network.
Our Therapeutic Accelerator is designed to provide exactly that. Over four months, you'll receive hands-on support to progress your therapeutic and lead its development with confidence, whatever path your science takes.
Applications for the 2027 cohort have now closed. The 2028 cohort will open for applications in Summer 2027.
Backed by Cancer Research UK and Cancer Research Horizons' world-leading network
A world-leading network
From biological assets and clinical networks to datasets, patient insights, commercialisation expertise and investor relationships, you'll have the resources and network of one of the world's leading cancer research organisations behind your work.
We go deep on oncology
Unmatched oncology expertise
Our curriculum, mentors and community focus exclusively on oncology therapeutics, giving you access to people who understand your science and what it takes to bring cancer therapies to patients.
We help you take the right path for your project
Multiple pathways
Not all promising therapeutic research becomes a venture-backed company, and our model is built with that in mind — licensing, partnership, in-house development or our seed funding, we'll get behind the route that fits your science.
You stay in control
No equity upfront
We offer £40k funding per participating team, plus the opportunity to pitch for one of two £250k awards. Investment and equity decisions come after the programme, giving you the space to learn, build and develop your science further.
Interested in supporting the programme?
Get involved as a partner, sponsor or mentor.
Contact us: [email protected]